Real world study of prostate cancer burden, care, and cost in Switzerland
Description
Prostate cancer (PC) is the most common cancer in men in Switzerland. To date there are only limited data and systematic analyses on the epidemiology, disease trajectory, clinical management, and cost of care for PC in Switzerland.
In light of its high prevalence, disease burden and societal impact there is a need for comprehensive understanding of the care currently provided and the cost implications for the health care system.
The aim of this study is to describe the treatment, costs and disease burden of PC in Switzerland.
Key data
Projectlead
Project team
Dr. Michael Stucki, Louisa Cakir
Project status
ongoing, started 01/2024
Institute/Centre
Winterthur Institute of Health Economics (WIG)
Funding partner
Janssen-Cilag AG
School of Management and Law
Gertrudstrasse 8
8400 Winterthur